A stem cell epigenome is associated with primary nonresponse to CD19 CAR T-cells in pediatric acute lymphoblastic leukemia.
Masih KE, Gardner RA, Chou H-C, Abdelmaksoud A, Song YK, Mariani L, Gangalapudi V, Gryder BE, Wilson ALauren, Adebola SO, et al. A stem cell epigenome is associated with primary nonresponse to CD19 CAR T-cells in pediatric acute lymphoblastic leukemia. Blood Adv. 2023.